Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur J Med Res ; 27(1): 47, 2022 Mar 26.
Artigo em Inglês | MEDLINE | ID: mdl-35346371

RESUMO

OBJECTIVES: This study aimed to systematically review the literature on the prevalence of hepatitis C virus (HCV) and hepatitis B virus (HBV) infections in transgender and LGBT people and determine their pooled estimates worldwide. METHODS: Databases (PubMed, Scopus, Web of Science, Embase, Ovid, Cochrane, PsycInfo) were searched from April 2000 to July 2021. The analyses were executed using the random-effects model in Stata 16. RESULTS: Ten studies, including eight studies on four transgender people and two studies on 2150 LGBTs, were included. The pooled prevalence of HCV and HBV in all transgender populations globally were 9% (95% CI 3-15%) and 11% (95% CI 2-20%), respectively. The corresponding prevalence in male-to-female transgender people were estimated as 5% (95% CI 1-9%) and 6% (95% CI 3-10%), respectively. These estimates in American transgenders were 10% (95% CI 5-25%) and 16% (95% CI 8-23%), respectively. CONCLUSION: This study was identified the overall prevalence of HBV and HCV infections in transgender people, which were higher than those in the general population.


Assuntos
Hepatite B , Hepatite C , Minorias Sexuais e de Gênero , Pessoas Transgênero , Feminino , Hepacivirus , Hepatite B/epidemiologia , Hepatite C/epidemiologia , Humanos , Masculino , Prevalência , Estados Unidos
2.
Asia Pac J Clin Oncol ; 18(2): e96-e102, 2022 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-33629817

RESUMO

INTRODUCTION: Gastric cancer (GC), the leading cause of cancer mortality, is the third most common cancer in Iran. To our knowledge, there have been few accurate estimates on the burden of GC in Iran. Therefore, as part of the Global Burden of Diseases Study 2017 (GBD 2017), we aimed to study and illustrate the burden of GC and to compare rates by sex and age groups at the national level in Iran from 1990 to 2017. METHODS: We extracted data related to the 1990-2017 period from the GBD study. To report the burden of GC, we used disability adjusted life years (DALYs), mortality, incidence, and prevalence rates in different sex and age groups in Iran during the 1990-2017 period. Decomposition analysis was also performed to evaluate the roots change in incident cases. RESULTS: At a national level, the age-standardized prevalence rate (ASPR), age-standardized incidence rate (ASIR), age-standardized mortality rate (ASMR), and age-standardized DALYs rate (ASDR) in 2017 were 22.9 (95% uncertainty interval [UI]: 22.1-23.9), 14.6 (14.1-15.2), 14.9 (14.4-15.4), and 296.8 (286.3-308.7) per 100,000 population, respectively. Over the 1990-2017 period, the average annual percent changes in all of the studied age-standardized rates were negative. Moreover, the male to female sex ratios of all estimates were greater than one. The incidence rate, prevalence rate, and mortality rate slowly began to increase at the age of 50 and reached its highest level among people aged 80 years and over. CONCLUSION: The GC age-standardized rates revealed a downward trend from 1990 to 2017. The current study provides comprehensive knowledge about the GC burden in Iran. Therefore, it can help the appropriate allocation of resources for GC to expand preventive programs by reducing exposure to risk factors and Helicobacter pylori infection and by recommending increased consumption of fruits and vegetables. Also, expanding GC screening programs with laboratory tests or endoscopy can be an important step towards the reduction of the GC burden.


Assuntos
Infecções por Helicobacter , Helicobacter pylori , Neoplasias Gástricas , Idoso de 80 Anos ou mais , Feminino , Carga Global da Doença , Saúde Global , Humanos , Incidência , Irã (Geográfico)/epidemiologia , Masculino , Anos de Vida Ajustados por Qualidade de Vida , Fatores de Risco , Neoplasias Gástricas/epidemiologia
3.
Arch Iran Med ; 24(5): 405-408, 2021 05 01.
Artigo em Inglês | MEDLINE | ID: mdl-34196206

RESUMO

The coronavirus epidemic first broke out in China in 2019 and spread around the world. Not only the signs, symptoms, and outcomes of the coronavirus in neonates, but also its vertical transmission risks are still unknown. This case series presents eight neonates born to mothers with COVID-19 and two neonates with this infection.


Assuntos
COVID-19/diagnóstico , COVID-19/transmissão , Transmissão Vertical de Doenças Infecciosas , Complicações Infecciosas na Gravidez/diagnóstico , Complicações Infecciosas na Gravidez/terapia , Adulto , COVID-19/terapia , Feminino , Humanos , Recém-Nascido , Irã (Geográfico) , Masculino , Gravidez , Complicações Infecciosas na Gravidez/virologia
4.
Clin Case Rep ; 9(5): e04212, 2021 May.
Artigo em Inglês | MEDLINE | ID: mdl-34026188

RESUMO

In this study, a case of Griscelli Syndrome (GS) in a 7 years old girl was reported. The patient initially presented with fever and pancytopenia in laboratory results; after ruling out the malignancies, she went under treatment with the diagnosis of infectious disease and was discharged after two weeks. Nevertheless, ten days after discharge, she developed new symptoms. Due to patient symptoms and general appearance, microscopic analysis of her hair shaft was done, and the abnormal distribution of pigments in the shaft was observed, indicating GS.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...